{
"id":"mk19_b_pm_t13",
"number":13,
"bookId":"pm",
"title":{
"__html":"Drugs Used in the Treatment of COPD"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"33bf24",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 13. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_pm_t13"
}
]
},
"Drugs Used in the Treatment of COPD"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"744605",
"class":"col hd l",
"children":[
"Agent"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b8bc11",
"class":"col hd l",
"children":[
"Adverse Effects"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f4c6f8",
"class":"col hd l",
"children":[
"Notes"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"3"
},
"children":[
" ",
{
"type":"p",
"hlId":"8313e7",
"class":"col hd l",
"children":[
"Bronchodilators"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"55e22b",
"class":"cell txt l",
"children":[
"Inhaled short-acting β",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
"-agonists (albuterol, fenoterol, levalbuterol, metaproterenol, pirbuterol, terbutaline)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9166cc",
"class":"cell txt l",
"children":[
"Tachycardia and hypokalemia (usually dose dependent), but generally well tolerated by most patients"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d034db",
"class":"cell txt l",
"children":[
"Generally used as needed for mild disease with few symptoms"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"59f522",
"class":"cell txt l",
"children":[
"Inhaled short-acting anticholinergic agents (ipratropium)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f602f0",
"class":"cell txt l",
"children":[
"Dry mouth, mydriasis on contact with eye, tachycardia, tremors; rarely acute narrow-angle glaucoma; this drug class has been shown to be safe in a wide range of doses and clinical settings"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"940997",
"class":"cell txt l",
"children":[
"Generally used as needed for mild disease with few symptoms; avoid using both short- and long-acting anticholinergics"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a594a4",
"class":"cell txt l",
"children":[
"Inhaled long-acting anticholinergic agents (tiotropium, aclidinium, umeclidinium, glycopyrrolate)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"16b1ee",
"class":"cell txt l",
"children":[
"Dry mouth, mydriasis on contact with eye, tachycardia, tremors; rarely acute narrow-angle glaucoma"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9e8739",
"class":"cell txt l",
"children":[
"Not to be used with ipratropium; use when short-acting bronchodilators provide insufficient control of symptoms"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1f985b",
"class":"cell txt l",
"children":[
"Inhaled long-acting β",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
"-agonists (salmeterol, formoterol, arformoterol, indacaterol, olodaterol)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ebba80",
"class":"cell txt l",
"children":[
"Sympathomimetic symptoms such as tremor and tachycardia; overdose can be fatal"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ee856f",
"class":"cell txt l",
"children":[
"Use as maintenance therapy when short-acting bronchodilators provide insufficient control of symptoms; not intended to be used for treatment of exacerbations of COPD or acute bronchospasm"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"cb65f5",
"class":"cell txt l",
"children":[
"Methylxanthines (theophylline, aminophylline; sustained and short-acting)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3f4524",
"class":"cell txt l",
"children":[
"Tachycardia, nausea, vomiting, and disturbed sleep; narrow therapeutic index; overdose can be fatal with seizures and arrhythmias"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"18db6a",
"class":"cell txt l",
"children":[
"Used as maintenance therapy; generally used only after long-acting bronchodilator treatment to provide additional symptomatic relief of exacerbations; may also improve respiratory muscle function"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"dc8bf5",
"class":"cell txt l",
"children":[
"Oral β",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
"-agonists (albuterol, metaproterenol, terbutaline)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bd85bf",
"class":"cell txt l",
"children":[
"Sympathomimetic symptoms such as tremor and tachycardia"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d2ca0c",
"class":"cell txt l",
"children":[
"Used as maintenance therapy; rarely used because of adverse effects but may be beneficial for patients who cannot use inhalers"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"3"
},
"children":[
" ",
{
"type":"p",
"hlId":"483a50",
"class":"col hd l",
"children":[
"Oral Phosophodiesterase-4 Inhibitor"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"41b167",
"class":"cell txt l",
"children":[
"Roflumilast"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"840889",
"class":"cell txt l",
"children":[
"Diarrhea, nausea, backache, decreased appetite, dizziness"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5c173e",
"class":"cell txt l",
"children":[
"Used to reduce risk for exacerbations in patients with severe COPD with chronic bronchitis and history of exacerbations; roflumilast should not be used with methylxanthines because of potential toxicity"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"3"
},
"children":[
" ",
{
"type":"p",
"hlId":"9d19ff",
"class":"col hd l",
"children":[
"Anti-Inflammatory Agents"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_3-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ea96e9",
"class":"cell txt l",
"children":[
"Inhaled glucocorticoids (fluticasone, budesonide, mometasone, ciclesonide, beclomethasone, flunisolide)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e29513",
"class":"cell txt l",
"children":[
"Dysphonia, skin bruising, oral candidiasis; rarely adverse effects of oral glucocorticoids (see below)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6c6025",
"class":"cell txt l",
"children":[
"Most effective in patients with a history of frequent exacerbations and when used in conjunction with long-acting bronchodilators"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_3-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"96a435",
"class":"cell txt l",
"children":[
"Oral glucocorticoids (prednisone, prednisolone)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"207fda",
"class":"cell txt l",
"children":[
"Skin bruising, adrenal suppression, glaucoma, osteoporosis, diabetes mellitus, systemic hypertension, pneumonia, cataracts, opportunistic infection, insomnia, mood disturbance"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"076d3d",
"class":"cell txt l",
"children":[
"Use for significant exacerbations of COPD; avoid, if possible, in stable COPD to limit glucocorticoid toxicity; consider inhaled glucocorticoids to facilitate weaning of systemic glucocorticoids"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"3"
},
"children":[
" ",
{
"type":"p",
"hlId":"4172b5",
"class":"col hd l",
"children":[
"Combination Agents"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_4-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"23383f",
"class":"cell txt l",
"children":[
"Combined inhaled long-acting β",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
"-agonist and inhaled glucocorticoid in a single inhaler (fluticasone/salmeterol, budesonide/formoterol, mometasone/formoterol)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ac4caa",
"class":"cell txt l",
"children":[
"Same/combined effects of both drug classes"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_4-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"cc0709",
"class":"cell txt l",
"children":[
"Combined short-acting β",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
"-agonist plus short-acting anticholinergic in a single inhaler (fenoterol/ipratropium, albuterol/ipratropium)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ac4caa",
"class":"cell txt l",
"children":[
"Same/combined effects of both drug classes"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"13ef17",
"class":"cell txt l",
"children":[
"Generally used as needed for mild disease with few symptoms; avoid using both short- and long-acting anticholinergics; this combination therapy may be used for maintenance therapy only if patients have well-controlled disease on this combination treatment and do not require rescue therapy if/when expense is a determining factor"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_4-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"80f2cd",
"class":"cell txt l",
"children":[
"Combined inhaled glucocorticoid and ultra-long-acting β",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
"-agonist in a single inhaler (fluticasone/vilanterol)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ac4caa",
"class":"cell txt l",
"children":[
"Same/combined effects of both drug classes"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"97eebf",
"class":"cell txt l",
"children":[
"Not to be used for treatment of acute bronchospasm"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_4-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"50f39f",
"class":"cell txt l",
"children":[
"Combined long-acting anticholinergic plus ultra-long-acting β",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
"-agonist in a single inhaler (umeclidinium/vilanterol)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ac4caa",
"class":"cell txt l",
"children":[
"Same/combined effects of both drug classes"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f903d3",
"class":"cell txt l",
"children":[
"Not to be used for treatment of acute bronchospasm; avoid using both short- and long-acting anticholinergics"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_4-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f3605a",
"class":"cell txt l",
"children":[
"Combined long-acting anticholinergic plus long-acting β",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
"-agonist in a single inhaler (olodaterol/glycopyrrolate, indacaterol/glycopyrrolate, glycopyrrolate/formoterol, olodaterol/tiotropium)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ac4caa",
"class":"cell txt l",
"children":[
"Same/combined effects of both drug classes"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f903d3",
"class":"cell txt l",
"children":[
"Not to be used for treatment of acute bronchospasm; avoid using both short- and long-acting anticholinergics"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_4-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"986191",
"class":"cell txt l",
"children":[
"Combined long-acting anticholinergic plus long-acting β",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
"-agonist plus inhaled corticosteroid in a single inhaler (fluticasone/umeclidinium/vilanterol)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ac4caa",
"class":"cell txt l",
"children":[
"Same/combined effects of both drug classes"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f903d3",
"class":"cell txt l",
"children":[
"Not to be used for treatment of acute bronchospasm; avoid using both short- and long-acting anticholinergics"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[

]
}